Maybe you started on a random day and want to align with a more convenient one
The Phase 3 programme , understood to be known as the TRIUMPH trials, is now underway and is evaluating retatrutide across broader and more diverse patient populations, including individuals with: Obesity without type 2 diabetes Obesity with type 2 diabetes Obesity-related cardiovascular disease Metabolic dysfunction-associated steatohepatitis (MASH) Readers seeking the most current information on trial status, registered populations, and endpoints are encouraged to consult ClinicalTrials.gov directly, where Phase 3 trial registrations for retatrutide can be found
They work well for some people and unlike the narrative that really is getting pushed right now that they are lifelong, they do not have to be
This incidence is comparable to whats observed in individuals using different GLP-1 medications, such as semaglutide
Key Takeaways 3 in 10 weight-conscious Americans have delayed or skipped a trip due to weight, mobility, or health concerns
See why we love Polaris Research